©2014 Baishideng Publishing Group Inc.
World J Hepatol. May 27, 2014; 6(5): 306-314
Published online May 27, 2014. doi: 10.4254/wjh.v6.i5.306
Published online May 27, 2014. doi: 10.4254/wjh.v6.i5.306
Table 1 Diagnostic criteria of the metabolic syndrome
| Criteria | Consensual criteria definition1 | Other non-consensual criteria |
| Central obesity | Abdominal waist2 | Different cutoff values of BMI ≥ 28 or ≥ 28.8 or ≥ 30 kg/m2 |
| > 102 cm (United States) or 94 cm (Europe) in men | ||
| > 88 cm (United States) or 80 cm (Europe) in women | ||
| Dyslipidemia | Triglycerides ≥ 150 mg/dL (1.7 mmol/L) | Statin or fenofibrate medication3 |
| HDL cholesterol | ||
| < 40 mg/dL (1.03 mmol/L) in men | ||
| < 50 mg/dL (1.29 mmol/L) in women | ||
| Hypertension | Blood pressure > 135/85 mmHg | Any antihypertensive therapy3 |
| Glucose intolerance | Hyperglycemia | Any diabetes Any antidiabetic therapy (oral or insulin) |
| Fasting glucose ≥ 110 mg/dL, | ||
| or type II diabetes |
- Citation: Cauchy F, Fuks D, Zarzavadjian Le Bian A, Belghiti J, Costi R. Metabolic syndrome and non-alcoholic fatty liver disease in liver surgery: The new scourges? World J Hepatol 2014; 6(5): 306-314
- URL: https://www.wjgnet.com/1948-5182/full/v6/i5/306.htm
- DOI: https://dx.doi.org/10.4254/wjh.v6.i5.306